We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TGTX market cap is 2.47B. The company's latest EPS is USD 0.0821 and P/E is 197.20.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 95k | 80k | 7.8M | 16.07M | 165.81M |
| Operating Income | -34.96M | -52.06M | -36.99M | -44.67M | 114.78M |
| Net Income | -35.82M | -52.99M | -39.23M | -47.61M | 113.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 152k | 152k | 6.69M | 2.79M | 233.66M |
| Operating Income | -169.06M | -273.59M | -344.77M | -192.84M | 20.63M |
| Net Income | -172.87M | -279.38M | -348.1M | -198.34M | 12.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 217.89M | 193.57M | 197.36M | 220.85M | 331.07M |
| Total Liabilities | 117.41M | 134.99M | 169.93M | 180.4M | 166.3M |
| Total Equity | 100.48M | 58.59M | 27.43M | 40.45M | 164.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 163.01M | 625.64M | 379.63M | 193.57M | 329.59M |
| Total Liabilities | 124.4M | 106.29M | 142.48M | 134.99M | 169.09M |
| Total Equity | 38.62M | 519.35M | 237.15M | 58.59M | 160.5M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -152.3M | -176.17M | -59.9M | -101.91M | -18.2M |
| Investing | -36.28M | -20.01M | -6.17M | 24.33M | -5.9M |
| Financing | -440k | -391k | 25.24M | 72.29M | 72.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -132.81M | -214.51M | -295.63M | -176.17M | -31.41M |
| Investing | -718k | -24.51M | -332k | -20.01M | -50.65M |
| Financing | 204.21M | 679.83M | 41.42M | -391k | 72.71M |
| Market Cap | 2.47B |
| Price to Earnings Ratio | 197.20 |
| Price to Sales Ratio | 10.7 |
| Price to Cash Ratio | 26.9 |
| Price to Book Ratio | 15.58 |
| Dividend Yield | - |
| Shares Outstanding | 154.42M |
| Average Volume (1 week) | 7.61M |
| Average Volume (1 Month) | 3.98M |
| 52 Week Change | -49.09% |
| 52 Week High | 35.67 |
| 52 Week Low | 6.46 |
| Spread (Intraday) | 2.52 (15.03%) |
| Company Name | TG Therapeutics Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.tgtherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
